Table of Contents Author Guidelines Submit a Manuscript
International Journal of Reproductive Medicine
Volume 2016 (2016), Article ID 3480629, 8 pages
http://dx.doi.org/10.1155/2016/3480629
Clinical Study

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?

Obstetrics and Gynecology Department, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt

Received 9 April 2016; Revised 19 June 2016; Accepted 12 July 2016

Academic Editor: Samir Hamamah

Copyright © 2016 Hend S. Saleh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, “Report of the expert committee on the diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 26, supplement 1, pp. S5–S20, 2003. View at Google Scholar
  2. National Diabetes Information Clearinghouse (NIDC), Diabetes Overview, National Diabetes Information Clearinghouse. NIH Publication, 2008.
  3. A. C. Maymone, J.-P. Baillargeon, J. Ménard, and J.-L. Ardilouze, “Oral hypoglycemic agents for gestational diabetes mellitus?” Expert Opinion on Drug Safety, vol. 10, no. 2, pp. 227–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Ben-Haroush, Y. Yogev, and M. Hod, “Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes,” Diabetic Medicine, vol. 21, no. 2, pp. 103–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. B. E. Metzger, S. G. Gabbe, B. Persson et al., “International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy,” Diabetes Care, vol. 33, no. 3, pp. 676–682, 2010. View at Publisher · View at Google Scholar
  6. T. F. Esakoff, Y. W. Cheng, T. N. Sparks, and A. B. Caughey, “The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus,” American Journal of Obstetrics and Gynecology, vol. 200, no. 6, pp. 672–e4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. B. O'Sullivan, C. M. Mahan, D. Charles, and R. V. Dandrow, “Screening criteria for high risk gestational diabetic patients,” American Journal of Obstetrics and Gynecology, vol. 116, no. 7, pp. 895–900, 1973. View at Google Scholar · View at Scopus
  8. E. Cosson, M. Benchimol, L. Carbillon et al., “Universal rather than selective screening for gestational diabetes mellitus may improve fetal outcomes,” Diabetes and Metabolism, vol. 32, no. 2, pp. 140–146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. K. G. M. M. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Google Scholar · View at Scopus
  10. O. Langer, “A spectrum of glucose thresholds may effectively prevent complications in the pregnant diabetic patient,” Seminars in Perinatology, vol. 26, no. 3, pp. 196–205, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. American Diabetes Association, “Gestational diabetes mellitus,” Diabetes Care, vol. 26, supplement 1, pp. S103–S105, 2003. View at Publisher · View at Google Scholar
  12. M. K. Lindsay, W. Graves, and L. Klein, “The relationship of one abnormal glucose tolerance test value and pregnancy complications,” Obstetrics and Gynecology, vol. 73, no. 1, pp. 103–106, 1989. View at Google Scholar · View at Scopus
  13. O. Langer, “From educated guess to accepted practice: the use of oral antidiabetic agents in pregnancy,” Clinical Obstetrics and Gynecology, vol. 50, no. 4, pp. 959–971, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. H. T. de Lima, E. Lopes Rosado, P. A. Ribeiro Neves, R. C. Monteiro Machado, L. M. de Oliveira, and C. Saunders, “Systematic review; nutritional therapy in gestational diabetes mellitus,” Nutricion Hospitalaria, vol. 28, no. 6, pp. 1806–1814, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics, “ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes,” Obstetrics & Gynecology, vol. 98, no. 3, pp. 525–538, 2001. View at Google Scholar
  16. B. E. Metzger, T. A. Buchanan, D. R. Coustan et al., “Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus,” Diabetes Care, vol. 30, no. 2, pp. S251–S260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. De Veciana, C. A. Major, M. A. Morgan et al., “Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy,” The New England Journal of Medicine, vol. 333, no. 19, pp. 1237–1241, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Magon and V. Seshiah, “Gestational diabetes mellitus: non-insulin management,” Indian Journal of Endocrinology and Metabolism, vol. 15, no. 4, pp. 284–293, 2011. View at Publisher · View at Google Scholar
  19. N. Magon and V. Seshiah, “Gestational diabetes mellitus: insulinic management,” Journal of Obstetrics and Gynecology of India, vol. 64, no. 2, pp. 82–90, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Simmons, “Metformin treatment for type 2 diabetes in pregnancy?” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 24, no. 4, pp. 625–634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Kirpichnikov, S. I. McFarlane, and J. R. Sowers, “Metformin: an update,” Annals of Internal Medicine, vol. 137, no. 1, pp. 25–33, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Rai, D. Meenakshi, and A. Kamath, “Metformin—a convenient alternative to insulin for Indian women with diabetes in pregnancy,” Indian Journal of Medical Sciences, vol. 63, no. 11, pp. 491–497, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. “IADPSG Consensus Panel International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy,” Diabetes Care, vol. 33, no. 3, pp. 676–682, 2010. View at Publisher · View at Google Scholar
  24. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, supplement 1, pp. S62–S69, 2010. View at Publisher · View at Google Scholar
  25. K. Horvath, K. Koch, K. Jeitler et al., “Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis,” British Medical Journal, vol. 340, no. 7750, Article ID c1395, p. 796, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. C. A. Crowther, J. E. Hiller, J. R. Moss, A. J. McPhee, W. S. Jeffries, and J. S. Robinson, “Effect of treatment of gestational diabetes mellitus on pregnancy outcomes,” The New England Journal of Medicine, vol. 352, no. 24, pp. 2477–2486, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 30, supplement 1, pp. S42–S47, 2006. View at Publisher · View at Google Scholar
  28. N. Alwan, D. J. Tuffnell, and J. West, “Treatments for gestational diabetes,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD003395, 2009. View at Google Scholar · View at Scopus
  29. A. Verma, C. M. Boney, R. Tucker, and B. R. Vohr, “Insulin resistance syndrome in women with prior history of gestational diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 7, pp. 3227–3235, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. B. E. Metzger, L. P. Lowe, A. R. Dyer et al., “Hyperglycemia and adverse pregnancy outcomes,” The New England Journal of Medicine, vol. 358, no. 19, pp. 1991–2002, 2008. View at Google Scholar
  31. J. Kraemer, J. Klein, A. Lubetsky, and G. Koren, “Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety,” American Journal of Obstetrics and Gynecology, vol. 195, no. 1, pp. 270–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Langer, D. L. Conway, M. D. Berkus, E. M.-J. Xenakis, and O. Gonzales, “A comparison of glyburide and insulin in women with gestational diabetes mellitus,” The New England Journal of Medicine, vol. 343, no. 16, pp. 1134–1138, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. T. N. Nanovskaya, I. Nekhayeva, G. D. V. Hankins, and M. S. Ahmed, “Effect of human serum albumin on transplacental transfer of glyburide,” Biochemical Pharmacology, vol. 72, no. 5, pp. 632–639, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. L. E. Moore, D. Clokey, V. J. Rappaport, and L. B. Curet, “Metformin compared with glyburide in gestational diabetes: a randomized controlled trial,” Obstetrics and Gynecology, vol. 115, no. 1, pp. 55–59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. E. J. Coetzee and W. P. Jackson, “Themanagement of non insulin DM inpregnancy,” Diabetes Research and Clinical Practice, vol. 1, pp. 281–287, 1986. View at Google Scholar
  36. J. M. H. Lim, Y. Tayob, P. M. S. O'Brien, and R. W. Shaw, “A comparison between the pregnancy outcome of women with gestation diabetes treated with glibenclamide and those treated with insulin,” Medical Journal of Malaysia, vol. 52, no. 4, pp. 377–381, 1997. View at Google Scholar · View at Scopus
  37. E. Hellmuth, P. Damm, and L. Mølsted-Pedersen, “Oral hypoglycaemic agents in 118 diabetic pregnancies,” Diabetic Medicine, vol. 17, no. 7, pp. 507–511, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. R. J. Norman, J. X. Wang, and W. Hague, “Should we continue or stop insulin-sensitizing drugs during pregnancy?” Current Opinion in Obstetrics and Gynecology, vol. 16, no. 3, pp. 245–250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. J. A. Rowan, W. M. Hague, W. Gao, M. R. Battin, and M. P. Moore, “Metformin versus insulin for the treatment of gestational diabetes,” The New England Journal of Medicine, vol. 358, no. 19, pp. 2003–2015, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. C. J. Glueck, S. Bornovali, J. Pranikoff, N. Goldenberg, S. Dharashivkar, and P. Wang, “Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome,” Diabetic Medicine, vol. 21, no. 8, pp. 829–836, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. J. E. L. Goh, L. Sadler, and J. Rowan, “Metformin for gestational diabetes in routine clinical practice,” Diabetic Medicine, vol. 28, no. 9, pp. 1082–1087, 2011. View at Publisher · View at Google Scholar · View at Scopus